MoonLake Immunotherapeutics (MLTX) Sector
Health Care

(Current) $53.79
0.48 (0.9%) Open Price: 53.06

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients

(12/04/24) $53.06
(12/05/24) $53.31
(12/05/24) (Qty.)52,133
(12/04/24) $51.05
(12/04/24) $54.54
(11/17/24) $47.33
(12/01/24) $56.00
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing